Aligos Therapeutics, Inc. (ALGS)

Aligos Therapeutics Revenue

Aligos Therapeutics had revenue of $311.00K in the quarter ending March 31, 2025, a decrease of -68.46%. This brings the company's revenue in the last twelve months to $3.27M, down -76.29% year-over-year. In the year 2024, Aligos Therapeutics had annual revenue of $3.95M, down -74.60%.

• Revenue (ttm): $3.27M
• Revenue Growth: -76.29%
• P/S Ratio: 14.86
• Revenue / Employee: $46,714
• Employees: 70
• Market Cap: 44.42M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.95M	-11.58M	-74.60%
Dec 31, 2023	15.53M	1.62M	11.66%
Dec 31, 2022	13.91M	9.55M	219.04%
Dec 31, 2021	4.36M	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.